Systemic chemotherapy of mammary carcinoma.
D000588:Amines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use; D001391:Azo Compounds / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002208:Caproates / Q000627:therapeutic use; D002241:Carbohydrates / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005467:Floxuridine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D010166:Palliative Care; D011241:Prednisone / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000588:Amines; D000970:Antineoplastic Agents; D001389:Azirines; D001391:Azo Compounds; D002208:Caproates; D002241:Carbohydrates; D007093:Imidazoles; D008937:Mitomycins; D014227:Triazines; D005467:Floxuridine; D002699:Chlorambucil; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D011241:Prednisone; D008727:Methotrexate